Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts

Abstract Triple negative breast cancers (TNBC) present a poor prognosis primarily due to their resistance to chemotherapy. This resistance is known to be associated with elevated expression of certain anti-apoptotic members within the proteins of the BCL-2 family (namely BCL-xL, MCL-1 and BCL-2). Th...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Lisa Nocquet, Julie Roul, Chloé C. Lefebvre, Laurine Duarte, Mario Campone, Philippe P. Juin, Frédérique Souazé
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Nature Portfolio 2024-06-01
Schriftenreihe:	Scientific Reports
Schlagworte:	Apoptosis Breast cancer Cancer-associated fibroblasts BCL-2 family Chemotherapy
Online-Zugang:	https://doi.org/10.1038/s41598-024-64696-z
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!